Team:BostonU/Parts
From 2014.igem.org
Parts submitted for Bronze and Silver Medal Consideration
Part Name | Part Type | MoClo Level | Antibiotic Resistance | BBa Name |
---|---|---|---|---|
C0040_CI | Repressor Fusion Protein | Level 0 | Chloramphenicol | BBa_K1401600 |
C0080_CI | Repressor Fusion Protein | Level 0 | Chloramphenicol | BBa_K1401601 |
E0040m_ID | Reporter Fusion Protein | Level 0 | Chloramphenicol | BBa_K1401602 |
E0030_ID | Repressor Fusion Protein | Level 0 | Chloramphenicol | BBa_K1401603 |
pTet+pBad | Tandem Promoter | Level 0 | Chloramphenicol | BBa_K1401007 |
pBad+pTet | Tandem Promoter | Level 0 | Chloramphenicol | BBa_K1401008 |
Parts used to build and test Tandem Promoters
Part Name | Part Type | MoClo Level | Antibiotic Resistance | BBa Name |
---|---|---|---|---|
B0030m_BC | Ribosomal Binding Site | Level 0 | Chloramphenicol | BBa_K1114100 |
B0031m_BC | Ribosomal Binding Site | Level 0 | Chloramphenicol | BBa_K1114101 |
BCD2_BC | Bicistronic Design | Level 0 | Chloramphenicol | BBa_K1114107 |
BCD8_BC | Bicistronic Design | Level 0 | Chloramphenicol | BBa_K1114108 |
E1010m_CD | RFP Reporter with fixed illegal sites | Level 0 | Chloramphenicol | BBa_K1114211 |
B0015_DE | Terminator | Level 0 | Chloramphenicol | BBa_K1114301 |
BCD16_BC | Bicistronic Design | Level 0 | Chloramphenicol | BBa_K1114111 |
Parts used to build and test Fusion Proteins
Device Name | Device Description | Component Parts | Destination Vector | MoClo Level | Antibiotic Resistance | BBa Name |
---|---|---|---|---|---|---|
pI13B2Rm_FG | pRepressible | I13453_FB+BCD2_BC+E1010m_CD+B0015_DG | DVL1_FG | Level 1 | Kanamycin | BBa_K1401606 |
pR10B2C40_EF | pRepressible | R0010_EB+BCD2_BC+C0040_CD+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401607 |
pR10B2C40Y_EF | pRepressible with Fusion Protein | R0010_EB+BCD2_BC+C0040_CI+E0030_ID+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401608 |
pR10B2Gm_EF | pRepressible | R0010_EB+BCD2_BC+E0040m_CD+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401609 |
pR10B2Y_EF | pRepressible | R0010_EB+BCD2_BC+E0030_CD+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401610 |
pR40B2Rm_FG | pRepressible | R0040_FB+BCD2_BC+E1010m_CD+B0015_DG | DVL1_FG | Level 1 | Kanamycin | BBa_K1401611 |
pR10B2C80_EF | pRepressible | R0010_EB+BCD2_BC+C0080_CD+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401612 |
pR10B2C80Y_EF | pRepressible with Fusion Protein | R0010_EB+BCD2_BC+C0080_CI+E0030_ID+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_1401613 |
pR10B2C80Gm_EF | pRepressible with Fusion Protein | R0010_EB+BCD2_BC+C0080_CI+E0040m_ID+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401614 |
pR10B2C40Gm_EF | pRepressible with Fusion Protein | R0010_EB+BCD2_BC+C0040_CI+E0040m_ID+B0015_DF | DVL1_EF | Level 1 | Kanamycin | BBa_K1401615 |
pJ00B2C12m_AE | pConstitutive | J23100_AB+BCD2_BC+C0012m_CD+B0015_DE | DVL1_AE | Level 1 | Kanamycin | BBa_K1401616 |